NodThera

NodThera

Small molecule drug candidate to treat inflammatory diseases, as well as other drugs for neurodegenerative diseases and cancers
Saffron Walden United Kingdom (HQ), Seattle United States, Lexington United States

NodThera Company information

Edit
Employees
23 people
Ownership
Firm valuation
€200—300m (Dealroom.co estimates Jun 2020.)
  • Edit

Recent News about NodThera

Edit
LocationEdit
Suite 8, The Mansion Chesterford Research Park, Little Chesterford CB10 1XL, United Kingdom
Are you an employee or an investor of this company?
Add your profile